LIVTENCITY

This brand name is authorized in Canada, Israel, Lithuania, Romania, United States

Active ingredients

The drug LIVTENCITY contains one active pharmaceutical ingredient (API):

1 Maribavir
UNII PTB4X93HE1 - MARIBAVIR

Maribavir is a competitive inhibitor of the UL97 protein kinase. UL97 inhibition occurs at the viral DNA replication phase, inhibiting UL97 serine/threonine kinase by competitively inhibiting the binding of ATP to the kinase ATP-binding site, without affecting the concatemer maturation process, abolishing phosphotransferase inhibiting CMV DNA replication and maturation, CMV DNA encapsidation, and CMV DNA nuclear egress.

Read about Maribavir

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
LIVTENCITY Film-coated tablet European Medicines Agency (EU) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
J05AX10 J Antiinfectives for systemic use → J05 Antivirals for systemic use → J05A Direct acting antivirals → J05AX Other antivirals
Discover more medicines within J05AX10

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: CA Health Products and Food Branch Identifier(s): 02530740
Country: IL מִשְׂרַד הַבְּרִיאוּת Identifier(s): 9220
Country: LT Valstybinė vaistų kontrolės tarnyba Identifier(s): 1095951, 1095952
Country: RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale Identifier(s): W69408001, W69408002
Country: US FDA, National Drug Code Identifier(s): 64764-800

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.